Comparative efficacy and safety of adalimumab biosimilar (BCD-057) and innovator in patients with psoriasis vulgaris. Results of the BCD-057-2/CALYPSO phase III international, multicenter, randomized double-blind clinical trial

Т. V. Korotaeva; A. V. Samtsov; A. L. Bakulev; M. M. Kokhan; I. K. Minullin; O. A. Vylegzhanina; V. V. Dubensky; B. V. Khalilov; A. A. Khotko; O. S. Zykova; I. V. Chumachenko; A. M. Lukyanov; A. V. Artemyeva; S. I. Derbin; E. Yu. Stukalina; E. V. Chernyaeva; R. A. Ivanov

Modern Rheumatology Journal
Sovremennaâ revmatologiâ

ISSN 1996-7012 (Print)
ISSN 2310-158X (Online)

User

eng | рус

Modern Rheumatology Journal

Advanced search

Archives

Download this PDF file

Fullscreen

For citations:

Korotaeva ТV, Samtsov AV, Bakulev AL, Kokhan MM, Minullin IK, Vylegzhanina OA, Dubensky VV, Khalilov BV, Khotko AA, Zykova OS, Chumachenko IV, Lukyanov AM, Artemyeva AV, Derbin SI, Stukalina EY, Chernyaeva EV, Ivanov RA. Comparative efficacy and safety of adalimumab biosimilar (BCD-057) and innovator in patients with psoriasis vulgaris. Results of the BCD-057-2/CALYPSO phase III international, multicenter, randomized double-blind clinical trial. Sovremennaya Revmatologiya=Modern Rheumatology Journal. 2018;12(4):71-84. (In Russ.) https://doi.org/10.14412/1996-7012-2018-4-71-84

This work is licensed under a Creative Commons Attribution 4.0 License.

ISSN 1996-7012 (Print)
ISSN 2310-158X (Online)

* not an advertisement

Indexing Databases

* not an advertisement

Popular articles

Editor-in-Chief

Al. M. Lila

Article Tools

Indexing metadata

How to cite item

Finding References

Email this article (Login required)

Email the author (Login required)

About the Authors

Т. V. Korotaeva
V.A. Nasonova Research Institute of Rheumatology.
Russian Federation

Tatiana Viktorovna Korotaeva.

34A, Kashirskoe Shosse, Moscow 115522.

A. V. Samtsov
S.M. Kirov Military Medical Academy, Ministry of Defense of Russia.
Russian Federation

6Ж, Academician Lebedev St., Saint Petersburg 194044.

A. L. Bakulev
V.I. Razumovsky Saratov State Medical University, Ministry of Health of Russia.
Russian Federation

112, Bolshaya Kazachiya St., Saratov 410012.

M. M. Kokhan
Ural Research Institute of Dermatovenereology and Immunopathology.
Russian Federation

8, Scherbakov St., Yekaterinburg 620076.

I. K. Minullin
Republican Dermatovenereology Dispensary.
Russian Federation

4, Tolstoy St., Kazan 420012.

O. A. Vylegzhanina
Siberian District Medical Center, Federal Biomedical Agency of Russia.
Russian Federation

13, Kainskaya St., Novosibirsk 630007.

V. V. Dubensky
Tver State Medical University, Ministry of Health of Russia.
Russian Federation

3a, Karl Marx St., Tver 170001.

B. V. Khalilov
Kazan State Medical University, Ministry of Health of Russia.
Russian Federation

49, Butlerov St., Kazan 420012.

A. A. Khotko
Clinical Dermatovenereology Dispensary, Ministry of Health of the Krasnodar Territory.
Russian Federation

179, Rashpilevskaya St., Krasnodar 350020.

O. S. Zykova
Vitebsk Regional Clinical Center of Dermatovenereology and Cosmetology.
Russian Federation

27, Frunze Pr., Vitebsk, 210023.

I. V. Chumachenko
Mogilev Regional Dermatovenereology Dispensary.
Russian Federation

4, Sosnovaya St., Mogilev 212018, Republic of Belarus.

A. M. Lukyanov
City Clinical Dermatovenereology Dispensary.
Russian Federation

46A, Priluksksaya St., Minsk 220089, Republic of Belarus.

A. V. Artemyeva
ZAO «BIOCAD».
Russian Federation